Telos Rx review
Carries one of the deepest published catalogs in the ranking — compounded semaglutide and tirzepatide plus needle-free oral and microdosed routes, PT-141, intranasal NAD+ and a wall of recovery peptides — and backs it with a checkable LegitScript certification and HIPAA compliance, but the verdict docks it hard because every line is compounded, not FDA-approved, and the pricing turns opaque the moment you look past the headline GLP-1 tiers.
- Semaglutide
- $49/mo (microdosed, annual)
- Tirzepatide
- $99/mo (annual)
- Coverage
- Not publicly listed
- Brand-name
- Compounded only
The scorecard
Telos Rx scored on our six published factors. See the methodology.
What we like
- Unusually deep published menu — compounded semaglutide and tirzepatide alongside PT-141, intranasal NAD+, and recovery peptides (sermorelin, ipamorelin, CJC-1295, BPC-157)
- Needle-free and oral routes, including oral and microdosed tirzepatide, for the needle-averse
- LegitScript-certified and HIPAA-compliant, with US-based providers and pharmacies, plus HSA/FSA and free 48-hour shipping
- Low published GLP-1 entry — from $49/mo microdosed and $99/mo tirzepatide on annual plans
The caveats
- Everything is compounded, not FDA-approved — including the peptides, several of which are research-grade with limited human evidence
- Pricing turns opaque outside the headline GLP-1 tiers, and the cheapest rates require a long annual lock-in (short plans run $145/$199/$399 in the first month)
- No named clinicians or leadership, and only a thin body of public reviews
- States served are not published, so confirm your state is covered before you sign up
The verdict
Best for: Patients who want a single LegitScript-verified operator carrying far more than a GLP-1 — oral and microdosed options, peptides and bioidentical HRT — and will accept compounded-only meds and a long annual lock-in in exchange for the lowest published prices. Carries one of the deepest published catalogs in the ranking — compounded semaglutide and tirzepatide plus needle-free oral and microdosed routes, PT-141, intranasal NAD+ and a wall of recovery peptides — and backs it with a checkable LegitScript certification and HIPAA compliance, but the verdict docks it hard because every line is compounded, not FDA-approved, and the pricing turns opaque the moment you look past the headline GLP-1 tiers.
Ranked #13 of 539 providers we have reviewed — for comparison, read our ruling on CoreAge Rx, our #1 pick. In the ranking it sits between Enhance MD at #12, 85/100 above and Effecty at #14, 87/100 below, with the Curex ruling the next one down.
Telos Rx is one of 539 rulings in this ranking, which makes the fair next question who sits above it — our shortlist of Telos Rx alternatives answers it in order, with every score shown.If you would rather start from the top of the field, our full board of 539 providers is the place to start if you are still shortlisting. We have also ruled on it directly: CoreAge Rx vs Telos Rx goes to CoreAge Rx, 94/100 to 85/100.
Compare with other providers
The closest rulings to Telos Rx by Verdict Score — the realistic shortlist if you are weighing this one up.
- #14Effecty— A LegitScript-verified nationwide operator that pairs fair compounded pricing with real brand-name access.87/100
- #15Curex— One flat price for either molecule, an oral route for the needle-averse, and a LegitScript-verified nationwide footprint.87/100
- #16Ro— A heavyweight telehealth brand with brand-name access and a polished experience — but opaque compounded pricing.87/100
- #17yourEra— One of the rare compounded programs that puts its price on the page — $199 semaglutide and $299 tirzepatide, both molecules, nationwide — wrapped in a broader longevity menu, but the verdict holds it at mid-pack because everything is compounded, injectable-only, and the 50-state and results claims are self-reported with a thin independent track record.84/100
- #18Strut Health— The only program here selling the same molecule as a lozenge or an injection at the same price — the needle is genuinely optional, though the company carries an FDA warning letter from February 2026.84/100
- #19MadeMed— Publishes its price at every single dose, so the cost of the dose you titrate to is knowable on day one rather than a surprise at month four.84/100
Pricing, states and verification reflect Telos Rx's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on Telos Rx's site. Not medical advice; see our disclosure.